Literature DB >> 16733041

[Infliximab-induced hepatitis in a patient with Crohn's disease].

S Soto-Fernández, P González-Carro, A De Pedro-Esteban, M L Legaz-Huidobro, F Pérez-Roldán, O Roncero García-Escribano, M Valbuena-González, F Ruiz-Carrillo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16733041     DOI： 10.1157/13087475

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN： 0210-5705            Impact factor:   2.102


× No keyword cloud information.
  8 in total

Review 1.  Infliximab-related hepatitis: a case study and literature review.

Authors:  Francisco Colina; Aída Molero; Begoña Casís; Pilar Martínez-Montiel
Journal:  Dig Dis Sci       Date:  2013-05-05       Impact factor: 3.199

Review 2.  Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.

Authors:  Roberta Elisa Rossi; Ioanna Parisi; Edward John Despott; Andrew Kenneth Burroughs; James O'Beirne; Dario Conte; Mark Ian Hamilton; Charles Daniel Murray
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 3.  Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.

Authors:  Marwan Ghabril; Herbert L Bonkovsky; Clarissa Kum; Tim Davern; Paul H Hayashi; David E Kleiner; Jose Serrano; Jim Rochon; Robert J Fontana; Maurizio Bonacini
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-17       Impact factor: 11.382

4.  Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept.

Authors:  K M Carlsen; L Riis; O R Madsen
Journal:  Clin Rheumatol       Date:  2009-04-16       Impact factor: 2.980

Review 5.  Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review.

Authors:  Maurizio Pompili; Marco Biolato; Luca Miele; Antonio Grieco
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

Review 6.  Infliximab-related hepatitis: discussion of a case and review of the literature.

Authors:  Stefano Mancini; Elisa Amorotti; Sarah Vecchio; Maurizio Ponz de Leon; Luca Roncucci
Journal:  Intern Emerg Med       Date:  2010-01-27       Impact factor: 3.397

7.  Eculizumab hepatotoxicity in pediatric aHUS.

Authors:  Wesley Hayes; Sibylle Tschumi; Simon C Ling; Janusz Feber; Michael Kirschfink; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2014-11-22       Impact factor: 3.651

Review 8.  Biologic and Checkpoint Inhibitor-Induced Liver Injury: A Systematic Literature Review.

Authors:  Parth Shah; Vinay Sundaram; Einar Björnsson
Journal:  Hepatol Commun       Date:  2020-01-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.